Rankings
▼
Calendar
CRON Q1 2022 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$983M
Q1 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$28M
+79.1% YoY
Gross Profit
$8M
29.6% margin
Operating Income
-$40M
-139.9% margin
Net Income
-$41M
-143.7% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
-13.0%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$35M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$62M
Stockholders' Equity
$1.7B
Cash & Equivalents
$1.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$28M
$16M
+79.1%
Gross Profit
$8M
-$4M
+325.3%
Operating Income
-$40M
-$57M
+30.1%
Net Income
-$41M
-$203M
+79.9%
Revenue Segments
Cannabis Flower
$19M
74%
Cannabis Extracts
$6M
25%
Product and Service, Other
$92,000
0%
Geographic Segments
CANADA
$14M
54%
ISRAEL
$9M
36%
UNITED STATES
$2M
9%
← FY 2022
All Quarters
Q2 2022 →